Pfizer said the green light makes Hympavzi the first once-weekly subcutaneous treatment in the European Union for people with severe hemophilia B and the first to be administered via a pre-filled pen ...

Elahere, which won initial U.S. Food and Drug Administration approval in 2022 for platinum-resistant ovarian cancer and full approval earlier this year, was the key asset in AbbVie's $10.1 billion ...

AbbVie ABBV announced that the European Commission (“EC”) has granted marketing authorization to Elahere (mirvetuximab ...

Britain's competition watchdog fined U.S. firm Viatris 1.5 million pounds ($1.88 million) on Friday for violating an order during its investigation into Theramex's acquisition of European rights to ...

Get global perspectives and insights from CEOs on the biggest stories in business. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes ...

The NGOs want the Netherlands to ban the export and transit of weapons, weapon parts, and dual-use items to Israel. South Korea’s national security adviser says North plans to use the weapons to ...

Britain's competition watchdog fined U.S. firm Viatris 1.5 million pounds ($1.88 million) on Friday for violating an order ...

This guide can help you get started. By The Learning Network CreditClockwise, from top left: Bryan Denton for The New York Times, Ennio Leanza/European Pressphoto Agency, Alejandro Cegarra for ...

Europe has more than 350 companies valued over $1 billion. However, over the past decade only 15 European countries have seen initial public offerings of over $1 billion, with almost half of them in ...

Some institutions, particularly in emerging markets, have already started cutting rates, but many more are forecast to follow this year, including the US Federal Reserve, the European Central Bank ...

The European Commission (EC) has approved OPUVIZ 40 mg/mL solution for injection in a vial. OPUVIZ is a biosimilar ...

U.S. pharmaceutical giant Viatris Inc has been fined 7.58 million dirhams ($760,000) by Morocco's competition regulator for ...